Dulude, Jean-Philippe
Le Moël, Alice
Dallaire, Frédérick
Doyon, Josée
Urmey, Kirk
Marple, Eric
Leblanc, Guy
Basile, Georges
Mottard, Sophie
Isler, Marc
Leblond, Frederic
Gervais, Mai-Kim
Article History
Received: 2 August 2024
Accepted: 4 March 2025
First Online: 14 March 2025
Declarations
:
: Frédéric Leblond co-founded Reveal Surgical, a medical device company that seeks to commercialize a Raman spectroscopy system for intraoperative cancer detection.The other authors have no competing interests to declare.
: Informed and written consent was obtained from all participants. The study was approved by the Ethics Committee of the Maisonneuve-Rosemont Hospital, which follows guidelines from the Tri-council policy statement Ethical Conduct for Research Involving Humans – TCPS 2, and the United States Code of Federal Regulations overseeing human research.